Edition:
United Kingdom

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

2.40USD
19 Feb 2019
Change (% chg)

$-0.19 (-7.34%)
Prev Close
$2.59
Open
$2.61
Day's High
$2.61
Day's Low
$2.34
Volume
28,294
Avg. Vol
39,624
52-wk High
$4.35
52-wk Low
$1.25

Chart for

About

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain... (more)

Overall

Beta: 1.01
Market Cap(Mil.): $177.54
Shares Outstanding(Mil.): 42.17
Dividend: --
Yield (%): --

Financials

  AVXL.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -0.39 -- --
ROI: -95.21 8.92 14.45
ROE: -95.21 10.08 15.96

Earnings vs. Estimates